Conference & Events
Event Details
Technology Transfer (3 day)
This three-day interactive workshop is intended to provide an overview of the challenges that must be overcome in transferring manufacturing technology.
Date: 02 July 2012 08:30 - 04 July 2012 17:00
Event Subject(s):
Education
Venue
Window Conference Venue
13 Windsor Street
Islington
London
N1 8QG
United Kingdom
Find this location using Google Map
Useful link:
www.pharma-training-courses.com
Organiser Information
Organiser(s): PharmaTraining Ltd
Contact for Event Information
Name : Ms Judy Callanan
Address:
BioCity Nottingham
Pennyfoot Street
Nottingham
NG1 1GF
United Kingdom
Tel:
+44 (0)115 912 4249
Fax:
+44 (0) 207 681 3582
Email:
judy@pharma-training-courses.com
Contact Useful link:
www.pharma-training-courses.com
Additional Information
Speaker Information:
Course Leader:
Chris Barnett is an independent GMP and compliance consultancy. Chris has a talent for coaching and explaining complex regulations in a straightforward manner.
Guest Lecturer:
Michael Gamlen is Managing Director of Pharmaceutical Development Services Ltd,
a pharmaceutical consultancy based in Nottingham (UK). Dr Gamlen has over 30 years experience in the pharmaceutical industry.
Useful link:
http://www.pharma-training-courses.com/technology-trans...
Other information:
The focus of the course is on small-molecules and their formulations rather than biological products, although many of the issues faced and techniques discussed will be equally applicable.
Some of the benefits to be derived from this workshop include:
. An appreciation of where TT fits in the life cycle of a pharmaceutical product.
. An appreciation of the importance of planning and project
management in TT.
. An overview of the potential complexity of technology and product transfer.
. An outline of proven best practice in technology transfer.
. An opportunity to discuss current issues and challenges in technology transfer with peers and with an expert faculty.
. A consideration of “where next” as we move from traditionally-developed products to a world where products are developed using QbD techniques and controlled by PAT.
